EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease

Sophie Schröder, Ulrike Fuchs, Verena Gisa, Tonatiuh Pena, Dennis M Krüger, Nina Hempel, Susanne Burkhardt, Gabriela Salinas, Anna-Lena Schütz, Ivana Delalle, Farahnaz Sananbenesi, Andre Fischer iD

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-024-02787-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Sophie Schröder und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. Hauptthemen laut MEDLINE: Astrocytes, Alzheimer Disease, RNA, Long Noncoding, DNA-Binding Proteins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, NIA NIH HHS, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astrocytes provide crucial support for neurons, contributing to synaptogenesis, synaptic maintenance, and neurotransmitter recycling. Under pathological conditions, deregulation of astrocytes contributes to neurodegenerative diseases such as Alzheimer’s disease (AD). While most research in this field has focused on protein-coding genes, non-coding RNAs, particularly long non-coding RNAs (lncRNAs), have emerged as significant regulatory molecules. In this study, we identified the lncRNA PRDM16-DT as highly enriched in the human brain, where it is almost exclusively expressed in astrocytes. PRDM16-DT and its murine homolog, Prdm16os , are downregulated in the brains of AD patients and in AD models. In line with this, knockdown of PRDM16-DT and Prdm16os revealed its critical role in maintaining astrocyte homeostasis and supporting neuronal function by regulating genes essential for glutamate uptake, lactate release, and neuronal spine density through interactions with the RE1-Silencing Transcription factor (Rest) and Polycomb Repressive Complex 2 (PRC2). Notably, CRISPR-mediated overexpression of Prdm16os mitigated functional deficits in astrocytes induced by stimuli linked to AD pathogenesis. These findings underscore the importance of PRDM16-DT in astrocyte function and its potential as a novel therapeutic target for neurodegenerative disorders characterized by astrocyte dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesAlzheimer DiseaseRNA, Long NoncodingDNA-Binding ProteinsTranscription FactorsAnimalsHumansMiceMaleBrainNeuronsMice, Inbred C57BL

Stichwörter der Autor:innen

Alzheimer’s diseaseAstrocyteBrainLong-non-coding RNAPostmortem human brain

Substanzen

RNA, Long NoncodingDNA-Binding ProteinsTranscription FactorsPRDM16 protein, humanPrdm16 protein, mouse

Autor:innen und Institutionen

  • Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
  • Bioinformatics Unit, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
  • NGS- Integrative Genomics Core Unit, Institute of Pathology, University Medical Center, Göttingen, Germany.
  • Research Group for Genome Dynamics in Brain Diseases, German Center for Neurodegenerative Diseases, Göttingen, Germany.
  • Department of Pathology and Laboratory Medicine, Boston University School of Medicine, 670 Albany Street, Boston, MA, 02118, USA.
  • Department for Systems Medicine and Epigenetics, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany. afische2@gwdg.de.

ORCID-Profile: Andre Fischer

Förderung

  • Deutsche Forschungsgemeinschaft
  • NIA NIH HHS
  • Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft

Zitieren

APA

Schröder, S., Fuchs, U., Gisa, V., Pena, T., Krüger, D. M., Hempel, N., Burkhardt, S., Salinas, G., Schütz, A. L., Delalle, I., Sananbenesi, F., & Fischer, A. (2024). PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02787-x

Vancouver

Schröder S, Fuchs U, Gisa V, Pena T, Krüger DM, Hempel N, et al. PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02787-x

BibTeX
@article{Schrder2024,
  author = {Schröder, Sophie and Fuchs, Ulrike and Gisa, Verena and Pena, Tonatiuh and Krüger, Dennis M and Hempel, Nina and Burkhardt, Susanne and Salinas, Gabriela and Schütz, Anna-Lena and Delalle, Ivana and Sananbenesi, Farahnaz and Fischer, Andre},
  title = {PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer’s disease},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-024-02787-x}
}
Kostenlos starten →